Bioscience Managers' Invests in Canary Medical's Proprietary 'Smart' Implant Technology
Summary
The Canary Health Implantable Reporting Processor (CHIRP) uses innovative sensor and novel communication technology in medical devices to enable remote patient monitoring. "BioScience Managers Matt McNamara (Chief Investment Officer) says, "the Canary Medical technology has the capacity to deliver better patient outcomes, more efficient delivery of treatment and a reduction in the cost of healthcare provision. Canary is led by Bill Hunter, MD, a seasoned entrepreneur with previous experience founding and leading a successful medical device company based on breakthrough technology (Angiotech, which developed the TAXUS Drug-coated coronary stent implanted in millions of patients worldwide). BioScience Managers operates from offices in Australia and the UK and from bases that span three regions - Europe, North America and the Asia Pacific, from where it sources investment opportunities. It is part of the PhillipCapital Group, which has more than US $28 billion under management and whose network of offices in 16 countries around the world provides access to valuable local knowledge and business contacts.Find out more online at biosciencemanagers.com.